The Eurasian journal of medicine, 2018-10, Vol.50 (3), p.207-209
2018
Details
- Autor(en) / Beteiligte
- Titel
- Sulfasalazine-Induced Interstitial Fibrosis
- Ist Teil von
- The Eurasian journal of medicine, 2018-10, Vol.50 (3), p.207-209
- Ort / Verlag
- Turkey: AVES
- Erscheinungsjahr
- 2018
- Link zum Volltext
- Quelle
- Alma/SFX Local Collection
- Beschreibungen/Notizen
- Sulfasalazine has been used in the treatment of inflammatory bowel disease for over 60 years. Although the drug is frequently associated with gastrointestinal adverse effects, pulmonary adverse effects are very rare. Herein, we report a case of interstitial fibrosis resulting from 4-month sulfasalazine therapy for ulcerative colitis in a patient under long-term follow-up in our clinic due to chronic obstructive pulmonary disease.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1308-8734eISSN: 1308-8742DOI: 10.5152/eurasianjmed.2018.17302Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6263240
- Format
- –
- Schlagworte
- Anemia, Antibiotics, Arthralgia, Case Report, Case reports, Case studies, Chronic obstructive lung disease, Colitis, Complications and side effects, Dosage and administration, Drug therapy, Fibrosis, Gastrointestinal diseases, Headache, Hemolytic anemia, Hepatitis, Lung diseases, Medical schools, Nonsteroidal anti-inflammatory agents, Pulmonary fibrosis, Rash, Respiratory tract diseases, Risk factors, Sulfasalazine, Toxicity, Ulcerative colitis